Literature DB >> 26291285

Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons.

Johannes Piepgras1, Markus Höltje1, Klaus Michel1, Qin Li1, Carolin Otto1, Christoph Drenckhahn1, Christian Probst1, Michael Schemann1, Sven Jarius1, Winfried Stöcker1, Bettina Balint1, Hans-Michael Meinck1, Ralph Buchert1, Josep Dalmau1, Gudrun Ahnert-Hilger1, Klemens Ruprecht2.   

Abstract

OBJECTIVE: To characterize pathogenic effects of antibodies to dipeptidyl-peptidase-like protein 6 (DPPX), a subunit of Kv4.2 potassium channels, on gut and brain neurons.
METHODS: We identified a new patient with anti-DPPX encephalitis and analyzed the effects of the patient's serum and purified immunoglobulin G (IgG), and of serum of a previous patient with anti-DPPX encephalitis, on the activity of enteric neurons by voltage-sensitive dye imaging in guinea pig myenteric and human submucous plexus preparations. We studied the subcellular localization of DPPX by immunocytochemistry in cultured murine hippocampal neurons using sera of 4 patients with anti-DPPX encephalitis. We investigated the influence of anti-DPPX-containing serum and purified IgG on neuronal surface expression of DPPX and Kv4.2 by immunoblots of purified murine hippocampal neuron membranes.
RESULTS: The new patient with anti-DPPX encephalitis presented with a 2-month episode of diarrhea, which was followed by tremor, disorientation, and mild memory impairment. Anti-DPPX-IgG-containing sera and purified IgG increased the excitability and action potential frequency of guinea pig and human enteric nervous system neurons. Patient sera revealed a somatodendritic and perisynaptic neuronal surface staining that colocalized with the signal of commercial anti-DPPX and Kv4.2 antibodies. Incubation of hippocampal neurons with patient serum and purified IgG resulted in a decreased expression of DPPX and Kv4.2 in neuronal membranes.
CONCLUSIONS: Hyperexcitability of enteric nervous system neurons and downregulation of DPPX and Kv4.2 from hippocampal neuron membranes mirror the clinical phenotype of patients with anti-DPPX encephalitis and support a pathogenic role of anti-DPPX antibodies in anti-DPPX encephalitis.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26291285      PMCID: PMC4560062          DOI: 10.1212/WNL.0000000000001907

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  The CD26-related dipeptidyl aminopeptidase-like protein DPPX is a critical component of neuronal A-type K+ channels.

Authors:  Marcela S Nadal; Andrés Ozaita; Yimy Amarillo; Eleazar Vega-Saenz de Miera; Yuliang Ma; Wenjun Mo; Ethan M Goldberg; Yoshio Misumi; Yukio Ikehara; Thomas A Neubert; Bernardo Rudy
Journal:  Neuron       Date:  2003-02-06       Impact factor: 17.173

2.  Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.

Authors:  Ethan G Hughes; Xiaoyu Peng; Amy J Gleichman; Meizan Lai; Lei Zhou; Ryan Tsou; Thomas D Parsons; David R Lynch; Josep Dalmau; Rita J Balice-Gordon
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

3.  Anti-NMDAR encephalitis mimicking HaNDL syndrome.

Authors:  Carsten Finke; Annerose Mengel; Harald Prüss; Winfried Stöcker; Andreas Meisel; Klemens Ruprecht
Journal:  Cephalalgia       Date:  2014-03-11       Impact factor: 6.292

Review 4.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

5.  DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients.

Authors:  William Oliver Tobin; Vanda A Lennon; Lars Komorowski; Christian Probst; Stacey Lynn Clardy; Allen J Aksamit; Juan Pablo Appendino; Claudia F Lucchinetti; Joseph Y Matsumoto; Sean J Pittock; Paola Sandroni; Maja Tippmann-Peikert; Elaine C Wirrell; Andrew McKeon
Journal:  Neurology       Date:  2014-10-15       Impact factor: 9.910

6.  Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.

Authors:  Anna Boronat; Jeffrey M Gelfand; Nuria Gresa-Arribas; Hyo-Young Jeong; Michael Walsh; Kirk Roberts; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Bernardo Rudy; Josep Dalmau
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

Review 7.  Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients.

Authors:  Romana Höftberger; Maarten J Titulaer; Lidia Sabater; Balazs Dome; Anita Rózsás; Balazs Hegedus; Mir Alireza Hoda; Viktoria Laszlo; Hendrik Jan Ankersmit; Lutz Harms; Sabas Boyero; Alicia de Felipe; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

8.  Progressive encephalomyelitis with rigidity and myoclonus: a new variant with DPPX antibodies.

Authors:  Bettina Balint; Sven Jarius; Simon Nagel; Uwe Haberkorn; Christian Probst; Inga Madeleine Blöcker; Ramona Bahtz; Lars Komorowski; Winfried Stöcker; Andreas Kastrup; Martin Kuthe; Hans-Michael Meinck
Journal:  Neurology       Date:  2014-04-02       Impact factor: 9.910

9.  Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors.

Authors:  Toshika Ohkawa; Yuko Fukata; Miwako Yamasaki; Taisuke Miyazaki; Norihiko Yokoi; Hiroshi Takashima; Masahiko Watanabe; Osamu Watanabe; Masaki Fukata
Journal:  J Neurosci       Date:  2013-11-13       Impact factor: 6.167

10.  DPP6 Localization in Brain Supports Function as a Kv4 Channel Associated Protein.

Authors:  Brian D Clark; Elaine Kwon; Jon Maffie; Hyo-Young Jeong; Marcela Nadal; Pavel Strop; Bernardo Rudy
Journal:  Front Mol Neurosci       Date:  2008-10-23       Impact factor: 5.639

View more
  29 in total

Review 1.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Dipeptidyl-peptidase-like protein 6 encephalitis treated with immunotherapy.

Authors:  Lan Ye; Margret Schnegelsberg; Mark Obermann
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-28

Review 3.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 4.  NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture.

Authors:  Josep Dalmau
Journal:  Neurology       Date:  2016-12-06       Impact factor: 9.910

Review 5.  Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.

Authors:  Elisabeth P Golden; Steven Vernino
Journal:  Clin Auton Res       Date:  2019-05-15       Impact factor: 4.435

6.  DPPX antibody-associated encephalitis: Main syndrome and antibody effects.

Authors:  Makoto Hara; Helena Ariño; Mar Petit-Pedrol; Lidia Sabater; Maarten J Titulaer; Eugenia Martinez-Hernandez; Marco W J Schreurs; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2017-03-03       Impact factor: 9.910

Review 7.  Autoimmune Movement Disorders: a Clinical and Laboratory Approach.

Authors:  Josephe Archie Honorat; Andrew McKeon
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

Review 8.  Autoantibodies in neurological disease.

Authors:  Harald Prüss
Journal:  Nat Rev Immunol       Date:  2021-05-11       Impact factor: 53.106

Review 9.  Autoimmune synaptopathies.

Authors:  Sarah J Crisp; Dimitri M Kullmann; Angela Vincent
Journal:  Nat Rev Neurosci       Date:  2016-02       Impact factor: 34.870

Review 10.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.